TY  - CONF

T1  - Efficacy and safety of dupilumab in children aged 6-11 years with inadequately controlled severe atopic dermatitis: results from an open-label extension trial up to 1 year

JO  - BRITISH JOURNAL OF DERMATOLOGY

PY  - 2022/01/01

AU  - Paller AS

AU  - Cork MJ

AU  - Siegfried EC

AU  - Guttman-Yassky E

AU  - Simpson EL

AU  - Soong W

AU  - Xiao J

AU  - Wang Z

AU  - Chuang C-C

AU  - O'Malley JT

AU  - Bansal A

ED  - 

VL  - 186

IS  - 4

SP  - E159

EP  - E160

Y2  - 2024/12/22

ER  -